Guru Sonpavde/adventhealth.com
Oct 29, 2024, 10:29
Guru Sonpavde: Pleased to discuss bladder cancer highlights at ESMO East conference
Guru Sonpavde posted on LinkedIn:
“ESMO24 bladder cancer highlights: Pleased to discuss from AdventHealth Central Florida cancer Institute at the just concluded ESMO East conference Ft Lauderdale, Florida arranged by Total Health | Oncology.”
Dr. Guru Sonpavde is the Oncology and Phase I Clinical Trials Director at AdventHealth Central Florida and the Chair of Bladder Cancer Research. He is also a Professor of Medicine at the University of Central Florida. His primary focus is drug development, leading innovative clinical trials on novel immunotherapies and targeted therapies for genitourinary cancers, especially bladder cancer, along with prostate, kidney, penile, and testicular cancers.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 12:41
Feb 21, 2025, 12:39
Feb 21, 2025, 11:36
Feb 21, 2025, 11:29
Feb 21, 2025, 10:45